trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['solid tumor', 'pantumor', 'pancreatic', 't-dxd', 'basket study']
#asco23 : interim results of the destiny-pantumor02 basket study of t-dxd in her2-overexpressing solid tumors: responses in different tumor types and levels of her2 expression pancreatic cancer cohort discontinued for lack of efficacy ae profile as expected with t-dxd 
Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Views are mine https://t.co/F0nn6X9z9N…